Name: Vascular diseases from an clinical and research perspective
Start: 2021-11-03T14:00:00+01:00
End: 2021-11-03T16:00:00+01:00
Location: Technohal

Previous event Next event

Wednesday 3 November 2021 14:00 - 16:00

Merging expertise, the key to boost the clinical outcome in aneurysm treatment
Whether EVAR is useful for the individual patient with an AAA or whether this technique is considered to be a failed experiment is being discussed by respected clinicians and technicians with great passion and even fire. The various guidelines seem to be at odds with each other and also benchtop testing and clinical outcomes are often conflicting. Based on that, what should the clinician say when the patient asks, 'what would you do in my situation, doc’? This theme session sheds light on the future of EVAR from a historical perspective. Will you know what your advice would be to the AAA patient at the end of this session?

When: November 3
Time: 14.00 - 16.00
How: Live & Digital
For whom: All attendees
Host: Prof.dr. Bob Geelkerken & Erik Groot Jebbink

The programme

14.00 - 14.10	Welcome & Introduction Prof.dr. Bob Geelkerken - University of Twente & Medisch Spectrum Twente
14.10 - 14.30	The patient perspective Is endovascular aortic aneurysm treatment a failed experiment or a blessing to the patient Prof. Matthew Thompson - Endologix
14.35 - 14.50 14.50 - 15.05	The manufacturer perspective ...On Thrombogenicity Dr. Robbie Brodie - Terumo Aortic ...On exoskeleton Simon Overeem MSc. - Medtronic
15.10 - 15.25 15.25 - 15.40	Future perspectives in the aortic dynamics Pulsatility and expansion; friend or enemy of sustainability Jaimy Simmering MSc. - University of Twente & Medisch Spectrum Twente Desired and unwanted blood-vesselwall-graft interaction Prof.dr. Michel Reijnen
15.40 - 16.00	Panel discussion Moderated by Erik Groot Jebbink & Bob Geelkerken - University of Twente Panel members: Prof.dr. Michel Versluis, Prof.dr. Michel Reijnen, Simon Overeem MSc., Ir. Remke Burie MBA